In-Depth Analysis Of The Edible Vaccine Market: Key Opportunities And Challenges
Projected Growth and Size of the Edible Vaccine Market Through 2025
In recent years, the edible vaccine market has experienced robust growth. It is forecasted to increase from $8.77 billion in 2024 to $9.51 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. This growth during the historical period can be linked to breakthroughs in genetic engineering, limitations of conventional vaccines, progress in biopharming techniques, a global push for improved immunization, and heightened governmental funding and support.
Download a free sample of the edible vaccine market report:
Future Growth Outlook and Market Expansion Factors in Edible Vaccines
Looking ahead, the edible vaccine market is expected to expand further, reaching $13.35 billion by 2029 at an accelerated CAGR of 8.8%. This anticipated rise is driven by increasing demand for pandemic preparedness, innovations in plant biotechnology, growing acceptance of genetically modified foods among the public, solutions to cold chain logistics issues, and synergy with food security initiatives. Noteworthy trends anticipated during this timeframe include growth in animal health applications, more widespread biopharming use, personalized nutrition and vaccination strategies, environmentally sustainable vaccine development, and the creation of multi-antigen edible vaccines.
Understanding Edible Vaccines and Their Mechanism
Edible vaccines are produced using genetically altered plants or animals, delivering vaccination through the consumption of these modified foods rather than through injections. When people eat these foods-such as fruits or vegetables containing vaccine antigens-an immune response is triggered. This approach aims to provide an affordable and easily distributable alternative to traditional vaccines, particularly benefiting developing nations where access to conventional immunization methods can be limited.
View the full edible vaccine market report:
Rising Infectious Diseases Fueling Demand for Edible Vaccines
The increasing incidence of infectious diseases is a significant factor encouraging the edible vaccine market's expansion. Infectious diseases, caused by bacteria, viruses, fungi, or parasites, continue to spread rapidly due to globalization, climate change, urbanization, and growing antibiotic resistance. Edible vaccines offer a cost-effective, needle-free method to stimulate immunity by consuming genetically modified food that produces antigens. For example, the Centers for Disease Control and Prevention (CDC) reported in March 2024 that tuberculosis cases in the US increased from 8,320 in 2022 to 9,615 in 2023, with the incidence rate rising from 2.5 to 2.9 per 100,000 people. This trend highlights the urgent need for innovative vaccination methods like edible vaccines.
North America's Prominent Position in the Edible Vaccine Market
In 2024, North America held the largest share in the edible vaccine market. The comprehensive market report also covers other key regions including Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on market developments and opportunities.
Browse Through More Reports Similar to the Global Edible Vaccine Market 2025, By The Business Research Company
Edible Animal Fat Global Market Report 2025
Edible Films And Coatings Global Market Report 2025
Edible Flakes Global Market Report 2025
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email:...
The Business Research Company -
Follow Us On:
. LinkedIn: "
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment